The drug research and development process is highly complex, lengthy and expensive, yet essential for delivering safe and effective therapies to patients. Even though the process is reasonably well-defined, drug development programs are fundamentally different for each product, as the exact testing and submission requirements are shaped by many unique factors. To help our customers navigate this process, Charles River offers a wide range of products and services that span the entire drug discovery and development continuum and can be tailored to specific research conditions.

The Spontaneously Hypertensive Stroke Prone Rat (SHRSP)was isolated from Wistar-Kyoto...

Developed by Dr. Lewis from Wistar stock in the early 1950s. To Charles River from Tu...

A mutation occurred in a colony of outbred Zucker rats in the laboratory of Dr. Walt...

As study protocols become more complex, so too does the need to have an in vivo mode...

Okamoto, Kyoto School of Medicine, 1963, from outbred Wistar Kyoto male with marked ...

Contact Charles River Laboratories

Sandhoferweg 7
97633 Sulzfeld
Tel: +49 09761-40664
Fax: +49 09761-40679

251 Ballardvale Street,
MA 01887-0430
+1 978 658 6000
Company Website